Validating Cardiac Ion Channel assays on the IonFluxTM System for the CiPA Paradigm
Fluxion Biosciences
Nov 13, 2017 8:10:00 PM
At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
Fluxion Biosciences
Nov 13, 2017 8:10:00 PM